ChromaDex to Participate in the 17th Annual LD Micro Main Event

Rhea-AI Summary

ChromaDex Corp. (NASDAQ:CDXC), a leader in NAD+ research and healthy aging, has announced its participation in the 17th Annual LD Micro Main Event at the Luxe Sunset Boulevard Hotel, California on October 29th, 2024. CEO Rob Fried and CFO Ozan Pamir will deliver a presentation at 2:00pm PT (5:00pm ET). The event will showcase 150 companies and include private one-on-one meetings with institutional investors. ChromaDex management will be available for individual meetings throughout the day. Interested parties can watch the live presentation through a provided webcast link and access additional company information through the LD Micro profile page.

LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announced that it will be participating at the 17th Annual LD Micro Main Event at the Luxe Sunset Boulevard Hotel, California on October 29th, 2024. The event is expected to feature 150 companies, presenting in half-hour increments, as well as private 1:1 meetings.

ChromaDex’s Chief Executive Officer, Rob Fried, and Chief Financial Officer, Ozan Pamir, are scheduled to present on October 29th at 2:00pm Pacific Time (5:00pm Eastern Time).

ChromaDex management will also attend one-on-one meetings with institutional investors throughout the day. For those interested in having a meeting with ChromaDex, please visit www.ldmicro.com for more information.

We invite interested parties to watch ChromaDex’s live presentation by registering via this webcast link: https://me24.sequireevents.com

To view ChromaDex’s profile, please use this link: https://www.ldmicro.com/profile/CDXC

For additional information on ChromaDex, visit www.chromadex.com.

About ChromaDex:

ChromaDex Corp. (NASDAQ:CDXC) is the global authority on nicotinamide adenine dinucleotide (NAD+), with a focus on the science of healthy aging. The ChromaDex team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to other everyday stressors. NAD+ depletion is a contributor to age-related changes in health and vitality.

Setting the benchmark as the gold standard in scientific rigor and quality, ChromaDex is the innovator behind its clinically proven flagship ingredient, Niagen (patented nicotinamide riboside, or NR), the most efficient and superior-quality NAD+ booster available.

Niagen^® is the active ingredient in ChromaDex’s consumer products, sold as the brand Tru Niagen^®, the number one healthy-aging NAD+ supplement in the United States^†. Clinically proven to increase NAD+ levels, Tru Niagen is helping people around the world transform the way they age (available at www.truniagen.com). ChromaDex supplies pharmaceutical-grade Niagen^® to U.S. FDA-registered 503B outsourcing facilities, which compound and distribute intravenous and injectable Niagen^® for clinics. These pharmaceutical-grade Niagen^® products, known as Niagen IV and Niagen injections, are available exclusively at clinics with a prescription (www.niagenplus.com).

ChromaDex’s robust patent portfolio protects NR and other NAD+ precursors. ChromaDex maintains a website at www.chromadex.com, where copies of press releases, news, and financial information are regularly published.

^†Based on the top-selling dietary supplement brands by revenue per the largest U.S. e-commerce marketplace (as of 3/1/2023-2/29/2024).

View source version on businesswire.com: https://www.businesswire.com/news/home/20241023861213/en/

ChromaDex Media Contact:

Kendall Knysch, Senior Director of Media Relations & Partnerships

310-388-6706 ext. 689

kendall.knysch@chromadex.com

ChromaDex Investor Relations Contact:

Ben Shamsian

Lytham Partners

646-829-9701

shamsian@lythampartners.com

Source: ChromaDex Corporation

FAQ

When is ChromaDex (CDXC) presenting at the LD Micro Main Event 2024?

ChromaDex (CDXC) is scheduled to present at the LD Micro Main Event on October 29th, 2024, at 2:00pm Pacific Time (5:00pm Eastern Time).

Where is the 2024 LD Micro Main Event featuring ChromaDex (CDXC) being held?

The 17th Annual LD Micro Main Event featuring ChromaDex (CDXC) is being held at the Luxe Sunset Boulevard Hotel in California.

Who will represent ChromaDex (CDXC) at the 2024 LD Micro Main Event?

ChromaDex (CDXC) will be represented by Chief Executive Officer Rob Fried and Chief Financial Officer Ozan Pamir at the event.

How many companies are presenting at the 2024 LD Micro Main Event with ChromaDex (CDXC)?

The event is expected to feature 150 companies presenting in half-hour increments.